Veterinary Dermatology Drugs Market Growth Opportunities and Forecast till 2032
The Global Veterinary Dermatology Drugs Market Size was valued at USD 7.1 Billion in 2022 and is anticipated to reach USD 17.9 Billion by 2032 with a CAGR of 9.8% from 2023 to 2032.
Dermatology problems are highly common in dogs, and they are the second most common reason they are taken to the veterinarian. Because skin and fur are markers of dogs' and cats' overall health, every pet owner is aware of skin illnesses. Dogs, like people, can develop a range of skin diseases as a result of their environment or heredity. Skin allergies, bacterial infections, insect bites, hot spots, rashes, impetigo, mange, and dermatitis are all common problems seen by veterinarians. Skin disorders account for more than ten percent of all diseases seen in pets. Allergies can be seasonal, triggered by airborne particles like pollen, mould, or dander, or environmental, handed down genetically. Both will induce skin inflammation and itching. Medication or immunotherapy can be used to treat them. Any protrusion, lump, bump, or foreign growth on the dog's skin qualifies. It could be a benign cyst or lump, or it could be a dangerous tumor that requires removal and additional cancer treatments in the worst-case scenario. Cats, too, can develop a variety of skin disorders as a result of infections, bugs, or allergies. Itching, dry or flaky skin and over-grooming are the most prevalent symptoms. A veterinarian will be able to determine the source of the problem and begin therapy.
Parameter |
Veterinary Dermatology Drugs Market |
Veterinary Dermatology Drugs Market Size in 2022 |
US$ 7.1 Billion |
Veterinary Dermatology Drugs Market Forecast By 2032 |
US$ 17.9 Billion |
Veterinary Dermatology Drugs Market CAGR During 2023 – 2032 |
9.8% |
Veterinary Dermatology Drugs Market Analysis Period |
2020 - 2032 |
Veterinary Dermatology Drugs Market Base Year |
2022 |
Veterinary Dermatology Drugs Market Forecast Data |
2023 - 2032 |
Segments Covered |
By Animal Type, By Indication, By Route of Administration, By Distribution Channel, and By Region |
Veterinary Dermatology Drugs Market Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Bimeda, Inc, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva, Elanco, Merck & Co., Inc., Vetoquinol, Virbac, Vivaldis, and Zoetis. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Veterinary Dermatology Drugs Market Dynamics
Increasing expenditure on veterinary health care is expected to drive the market at a significant rate. More pets, more pet parents going to the vet, and a rise in vet expenditures due to labor and more modern treatments for vets drawn from human medicine are all putting a strain on the wallet. The cost of veterinary treatment has increased due to rising medicine and pharmaceutical prices, as well as the expense of new technology and medical equipment. The increased spending reflects not only higher costs but also a number of other reasons, such as a growth in the number of pets and longer pet lifespans, which necessitates more veterinarian care.
However, limited awareness in emerging countries may constrain market growth. Furthermore, the surge in prevalence of chronic skin diseases such as chewing, biting, and rubbing is likely to create numerous growth opportunities for the market in the coming years. Atopic dermatitis is an allergic skin disorder caused by harmless items such as grass, house dust mites, mould spores, and other allergens in the environment.
Global Veterinary Dermatology Drugs Market Segment Analysis
Veterinary Dermatology Drugs Market By Animal Type
· Livestock Animal
· Companion Animal
Companion animals typically dominate the veterinary dermatology drugs market. This segment includes pets such as dogs, cats, and horses, which often require treatment for various dermatological conditions like allergies, infections, and parasites. While livestock animals can also suffer from skin issues, the demand for dermatology drugs is generally higher among companion animals due to their close interaction with humans and the increasing trend toward pet ownership.
Veterinary Dermatology Drugs Market By Indication
· Allergic Infections
· Parasitic Infections
· Others
Allergic infections tend to dominate the veterinary dermatology drugs market. Allergies are a common issue in both companion and livestock animals, leading to various dermatological symptoms such as itching, redness, and skin inflammation. Therefore, there is a significant demand for drugs to manage allergic reactions in animals, driving the dominance of this indication in the veterinary dermatology drugs market.
Veterinary Dermatology Drugs Market By Route of Administration
· Topical
· Oral
· Injectable
The topical route of administration typically dominates the veterinary dermatology drugs market. This is because many dermatological conditions in animals, such as skin infections, allergies, and parasites, often require direct treatment at the site of the issue. Topical medications, such as creams, ointments, sprays, and shampoos, are commonly used to deliver drugs directly to the affected areas of the skin, making them the preferred choice for managing dermatological conditions in animals
Veterinary Dermatology Drugs Market By Distribution Channel
· E-Commerce
· Retail
· Hospital Pharmacies
E-commerce is increasingly dominating the veterinary dermatology drugs market. With the rise of online platforms, pet owners and veterinarians find it convenient to purchase veterinary drugs, including dermatology products, through e-commerce channels. This trend is driven by factors such as ease of access, a wide range of product options, competitive pricing, and the ability to compare products and read reviews. While retail stores and hospital pharmacies still play significant roles, the convenience and accessibility of e-commerce platforms have propelled them to dominance in the veterinary dermatology drugs market.
Veterinary Dermatology Drugs Market Regional Analysis
Based on regions, the global veterinary dermatology drugs industry is segmented into North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Among them, North America conquered the largest market share in 2022. The high adoption rate of pets in countries such as the US and Canada is the primary reason for the regional expansion. Every year, around 6.3 million companion animals are surrendered to animal shelters across the US. There are around 3.2 million cats and 3.1 million dogs among them. According to the American Pet Products Association, the country's pet population is expected to be 78 million dogs and 85.8 million cats. In the United States, around 44% of all homes have a dog, and 35% have a cat. Furthermore, the Asia-Pacific region is expected to attain the fastest growth rate during the predicted period 2021 – 2028. Increasing awareness among pet parents and growing veterinary hospitals in countries such as China and India are expected to surge the demand for APAC veterinary dermatology drugs market.
Veterinary Dermatology Drugs Market Leading Companies
The veterinary dermatology drugs market players profiled in the report are Bimeda, Inc, Bioiberica S.A.U., Boehringer Ingelheim International GmbH, Ceva, Elanco, Merck & Co., Inc., Vetoquinol, Virbac, Vivaldis, and Zoetis.
Veterinary Dermatology Drugs Market Regions
North America
· U.S.
· Canada
Europe
· U.K.
· Germany
· France
· Spain
· Rest of Europe
Latin America
· Brazil
· Mexico
· Rest of Latin America
Asia-Pacific
· China
· Japan
· India
· Australia
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· GCC
· South Africa
· Rest of Middle East & Africa